US regulatory status: approved. Molecular target: DNA.
- Target
- DNA
- Mechanism
- DNA inhibitor
pharma · Glioblastoma, IDH-wildtype · SHPH
Shuttle Pharmaceuticals Holdings
Shuttle Pharmaceuticals Holdings drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Rockville, USA HQ
2012 Founded
5 Employees
Public company Type
SHPH · NYSE Ticker
Company details
- Status
- Public
- HQ
- Rockville, USA
- Founded
- 2012
- Employees
- 5
- Programs
- 1
- Drugs
- 1
- Patents
- 9
Shuttle Pharmaceuticals Holdings pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Shuttle Pharmaceuticals Holdings drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.